Found: 23
Select item for more details and to access through your institution.
Chidamide plus R‐GDP for relapsed/refractory diffuse large B‐cell lymphoma in patients ineligible for autologous transplantation: A prospective, single‐arm, phase II study.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 16, p. 1, doi. 10.1002/cam4.70142
- By:
- Publication type:
- Article
Clinical Characteristics and Prognostic Factors in Primary Breast Diffuse Large BCell Lymphoma.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2022, v. 14, n. 1, p. 1, doi. 10.4084/MJHID.2022.066
- By:
- Publication type:
- Article
The early variation of left ventricular twisting function in patients with lymphoma received anthracycline therapy assessed by three-dimensional speckle tracking echocardiography.
- Published in:
- Cardiology Journal, 2017, v. 24, n. 5, p. 484, doi. 10.5603/CJ.a2017.0035
- By:
- Publication type:
- Article
Switching Fractioned R-CHOP Cycles to Standard R-CHOP Cycles Guided by Endoscopic Ultrasonography in Treating Patients with Primary Gastric Diffuse Large B-Cell Lymphoma.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 5041, doi. 10.2147/CMAR.S260974
- By:
- Publication type:
- Article
Radiotherapy followed by DICEP regimen in treatment of newly diagnosed, stage IE/IIE, extranodal NK/T‐cell lymphoma patients.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 15, p. 5400, doi. 10.1002/cam4.3207
- By:
- Publication type:
- Article
Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphoma.
- Published in:
- Cancer & Metabolism, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40170-020-00213-w
- By:
- Publication type:
- Article
Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer.
- Published in:
- International Journal of Nanomedicine, 2014, v. 9, p. 1443, doi. 10.2147/IJN.S58275
- By:
- Publication type:
- Article
Four cycles of R-CHOP followed by two applications of rituximab based on negative interim PET/CT: an analysis of a prospective trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Serum miR‐146a level is a potential biomarker in predicting the outcome of diffuse large B‐cell lymphoma.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2023, v. 19, n. 5, p. e283, doi. 10.1111/ajco.13911
- By:
- Publication type:
- Article
Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 2, p. 379, doi. 10.1007/s00432-015-2026-y
- By:
- Publication type:
- Article
Early changes in soluble intracellular adhesion molecule‐1 as prognostic biomarkers to immune checkpoint inhibitor.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 8, p. 1396, doi. 10.1111/cts.13540
- By:
- Publication type:
- Article
Combined taxane, platinum, and cetuximab as a first‐line treatment for recurrent/metastatic head and neck squamous cell carcinoma: Retrospective study.
- Published in:
- Head & Neck, 2022, v. 44, n. 9, p. 2040, doi. 10.1002/hed.27085
- By:
- Publication type:
- Article
Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab era.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 372, doi. 10.1007/s12185-022-03358-0
- By:
- Publication type:
- Article
Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-96
- By:
- Publication type:
- Article
Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway.
- Published in:
- 2014
- By:
- Publication type:
- journal article
PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib.
- Published in:
- BMC Cancer, 2011, v. 11, n. 1, p. 248, doi. 10.1186/1471-2407-11-248
- By:
- Publication type:
- Article
Interim PET/CT result is the sole prognostic factor of survival in patients with advanced-stage diffuse large B-cell lymphoma: a subset analysis of a prospective trial.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2021, v. 327, n. 1, p. 353, doi. 10.1007/s10967-020-07511-z
- By:
- Publication type:
- Article
An interactive nomogram to predict healthcare-associated infections in ICU patients: A multicenter study in GuiZhou Province, China.
- Published in:
- PLoS ONE, 2019, v. 14, n. 7, p. 1, doi. 10.1371/journal.pone.0219456
- By:
- Publication type:
- Article
Left atrial reservoir longitudinal strain and its incremental value to the left ventricular global longitudinal strain in predicting anthracycline-induced cardiotoxicity.
- Published in:
- Echocardiography, 2024, v. 41, n. 4, p. 1, doi. 10.1111/echo.15805
- By:
- Publication type:
- Article
Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 145, doi. 10.2147/OTT.S117007
- By:
- Publication type:
- Article
Prognostic significance of clinical characteristics and 18 Fluorodeoxyglucose-positron emission tomography/computed tomography quantitative parameters in patients with primary mediastinal B-cell lymphoma.
- Published in:
- Journal of International Medical Research, 2022, v. 50, n. 1, p. 1, doi. 10.1177/03000605211063027
- By:
- Publication type:
- Article
Anthracycline induced inconsistent left ventricular segmental systolic function variation in patients with lymphoma detected by three-dimensional speckle tracking imaging.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer.
- Published in:
- International Journal of Cancer, 2014, v. 135, n. 8, p. 1961, doi. 10.1002/ijc.28829
- By:
- Publication type:
- Article